Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)
Apply
IPH5201 & Durvalumab
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step